Treatment Efficacy for Drug Abuse and AIDS Prevention - 2

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 2

Conditions

Heroin Dependence
Cocaine-Related Disorders

Treatments

Drug: Buprenorphine

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000211
R18-06116-2
NIDA-06116-2

Details and patient eligibility

About

The purpose of this study is to assess the safety and effectiveness of buprenorphine for treatment of concurrent intravenous heroin and cocaine dependence.

Sex

Male

Ages

26 to 41 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems